Research and experimental development services | Tenderlake

Research and experimental development services

Contract Value:
EUR 964K - 964K
Notice Type:
Contract award notice
Published Date:
22 June 2023
Closing Date:
Location(s):
ES511 Barcelona (ES Spain/ESPAÑA)
ITF34 Avellino (IT Italy/ITALIA)
SE331 Västerbottens län (SE Sweden/SVERIGE)
Description:
Pre-Commercial Procurement to buy R&D services to deliver quick responses for individuals with advanced heart failure and complex care needs through integrated care (TIQUE PHASE 2)

This contract award notice informs interested operators about the outcome of PHASE 2 . On 18/04/2023 the tender procedure for Phase 2 was published as part of the EU project H2020 - TIQUE to purchase R&D services from a number of R&D providers in parallel (PCP procurement).

This phase 2 aims to develop, demonstrate, and validate defined prototypes in lab conditions. Participating companies are expected to deliver a Prototype specification, a Prototype demonstration, a Development Plan, an implementation plan of a limited volume of services for field- testing, and an Updated cost/benefits forecast incl. preliminary business plan. The total budget for R&D contracts in this phase is 1.350.000 € (including Spanish VAT) and the Maximum budget per contractor is 450.000 € (including Spanish VAT, 21%). From this sum it was expected that at least 3 contracts to be awarded. This phase lasts for 9 months and 12 days.

The procurement was announced in the form of a PCP with a phased approach framework agreement that covers 3 R&D phases:

- R&D up to solution design

- R&D up to a prototype

- R&D up to original development, validation and testing of a limited set of first products or services.

After each phase, intermediate evaluations are carried out to progressively select the best competing solutions. The contractors with the best-value-for-money solutions will be offered a specific contract for the next phase.

The total budget of 4,429,075 € (Spanish VAT, 21%, included) was earmarked for awarding the contracts to a minimum of:

- a minimum of four (4) contractors for phase 1

- a minimum of three (3) Phase 2 and

- a minimum of two (2) contractors for phase 3.

Sufficient amount of good quality tenders were received to award the planned amount of contracts.

The abstracts of the winning tenders are available on TIQUE (https://www.tiquepcp.eu/)

The procurement started on 31st May 2022 and it is expected to end on 9th December 2025. This date is indicative, but in any case, it will stick to the actual date of execution

Awarded to:
Pre-Commercial Procurement to buy R&D services to deliver quick responses for individuals with advanced heart failure and complex care needs through integrated care (TIQUE - PHASE 2)
ADDITIUM BLOCKCHAIN, S.L, Madrid (ES)
FOLLOWHEARTH, S.L, Barceolona (ES)
INSTITUTO DE BIOMECÁNICA DE VALENCIA (IBV), Valencia (ES)
IZERTIS, S.A., Gijón (ES)
MEDICINE MEN BV, Bunnik (SE)
TELEVES S.A.U., SANTIAGO DE COMPOSTELA (ES)
UMC UTRECHT, UTRECH (NL)
UNIVERSITAT POLITECNICA DE VALENCIA (UPV), Valencia (ES)
ZIEKENHUIS GELDERSE VALLEI, EDE (NL)
Download full details as .pdf
The Buyer:
Fundación de Gestión Sanitaria del Hospital de la Santa Creu i Sant Pau
CPV Code(s):
73100000 - Research and experimental development services